AV Fellows

Backing bold teams building market-defining companies to reshape and reinvent industries.

ARTIS Ventures is a leading early-stage venture capital firm in San Francisco, pioneering investments at the intersection of life sciences and computer sciences — what we call TechBio.

TechBio®

Over the past 15 years, Computer Science has seen tremendous progress in storage, networking, data analysis and computation power. The field of Life Science has also made tremendous strides in our understanding of biological processes and disease, leading to new therapies.

ARTIS invests at the convergence of these two industry trends. Investment focus areas include AI Drug Discovery, Synthetic Biology, Gene Editing, Digital Health, and more.

ARTIS Fellows will work closely with our investment team in due diligence, deal sourcing, and portfolio support.

Take part in shaping our Inaugural 6-month Fellows Program


Commit 10 hours per month remotely


Receive a competitive monthly stipend


Work directly with impactful healthcare startups


Learn about new cutting edge technologies on the TechBio frontier


Gain VC experience during a record setting market (2020: $51B invested in healthcare startups and $16B raised by healthcare VCs)

Why Join

Who Should Apply

Applicants should be currently enrolled in a PhD or MD program (or Post-Doc / Residency). Expertise or interest in one of the following areas is preferred:

01

Cell & Gene Therapy

02

Immunology

03

AI / Machine Learning

04

Genetics

05

Neuroscience

06

Synthetic Biology

07

Metabolic Disorders

AV Team

Applications for 2021 Now Open

Applications will close April 15, 2021. 
Upon acceptance, AV Fellows will commence their six month commitment. 
Please contact Megan Daugherty at md@av.co with any questions.

Artis Ventures is committed to increasing opportunities for underrepresented groups, promoting gender, racial, and ethnic diversity in the venture industry.